SPAC Presentation
Procaps at a Glance
Integrated Pharma Company Well Positioned to Drive Regional Consolidation
Founded in 1977 by the
Minski Family, Procaps is
a leading integrated
international healthcare
✪
and pharmaceutical
company
Largest pharmaceutical
integral CDMO (ICDMO) in
Latin America and top 3
globally in terms of volume of
softgel production capacity²
6 manufacturing facilities in
Latin America including first
FDA-approved
pharmaceutical plant in
South America
Gross Revenue
$388mm
2020
$436mm
2021E
We employ over
5,000 people across
13 countries
Adj. EBITDA¹
$90mm
2020
PROCAPS:
GROUP
$105mm
2021E
Our products are sold &
distributed in ~50
markets
PROCAPS
34 patents and
5,335
trademarks
Extensive Scientific
Expertise with more than
500 formulations,
developing more than 50
products per year
GROUP
Source: Procaps, QYR Research.
Note: (1) Adjusted by Severance & Other Non-Recurring Items, One-Time Trade Days Stabilization Impact, Synergies & Cost Savings and COVID Expenses; (2) QYR Research market report as of 2020
Vertically and
horizontally integrated
to provide drug delivery
technology and
manufacturing
capabilities
8View entire presentation